Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor
PHASE3
This study was a multi-center, randomized, double-blind, placebo controlled...
Status
Completed
Location
University of South Alabama / Mitchell Cancer Institute Deptof Mitchell Cancer Inst(2)
A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi
PHASE3
This study was a multicenter, randomized, double-blind, placebo-controlled ...
Status
Terminated
Location
University of South Alabama / Mitchell Cancer Institute Univ South AL
Study of Efficacy and Safety of Buparlisib (BKM120) Plus Paclitaxel Versus Placebo Plus Paclitaxel in Recurrent or Metastatic Head and Neck Cancer Previously Pre-treated With a Platinum Therapy
PHASE2
Phase II Study of efficacy and safety of buparlisib (BKM120) plus paclitaxe...
A Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K Activation
PHASE2
This study evaluated whether the addition of daily BKM120 to weekly paclita...